Literature DB >> 12167423

Molecular characterization of angiogenic properties of human oral squamous cell carcinoma cells.

Yi-Ju Chen1, Ying-Tai Jin, Dar-Bin Shieh, Sen-Tien Tsai, Li-Wha Wu.   

Abstract

Little is known about the specificity of angiogenic properties of oral cancer cells and the possible mechanisms. Stimulatory effects on proliferation and migration of human umbilical vein endothelial cells (HUVEC) characterized the angiogenic properties of oral cancer cells but not normal oral keratinocytes (NOK). ELISA found the presence of vascular endothelial growth factors (VEGF) both in the tested oral cancer cells and NOK. Attenuation of the proangiogenic effects by neutralizing VEGF antibodies suggests VEGF play a key role in the acquisition of the angiogenic phenotype in oral cancer cells. Western blotting of p53 and murine double mutant 2 (Mdm2) together with p53 DNA sequencing analysis indicate that p53 function loss by mutation or overexpression of Mdm2 occurred in all tested oral cancer cells regardless of their etiology. In summary, the angiogenic property of oral cancer cells is mediated by many factors in addition to VEGF and the functional status of p53.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167423     DOI: 10.1016/s1368-8375(02)00004-0

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  6 in total

1.  Possible implication of Mdm2 as a prognostic marker in invasive laryngeal carcinoma.

Authors:  Marcela K Hassumi-Fukasawa; Fabiana A Miranda-Camargo; Márcia C M Guimarães; Renata T Simões; Eduardo A Donadi; Christiane P Soares; Edson G Soares
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-02-05       Impact factor: 2.503

2.  Upregulation of serum vascular endothelial growth factor and matrix metalloproteinase-3 in patients with oral squamous cell carcinoma.

Authors:  Azadeh Andisheh-Tadbir; Bijan Khademi; Fereshteh Kamali; Mohammad Javad Fattahi; Mahyar Malekzadeh; Masumeh Taghva
Journal:  Tumour Biol       Date:  2014-02-28

3.  Bone morphogenetic protein 6 expression in oral cavity squamous cell cancer is associated with bone invasion.

Authors:  Alexandra E Kejner; M Benjamin Burch; Larissa Sweeny; Eben L Rosenthal
Journal:  Laryngoscope       Date:  2013-07-01       Impact factor: 3.325

4.  Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cells.

Authors:  Liliana P Cantini; Lourdes M Andino; Christopher C Attaway; Betsy Butler; Anca Dumitriu; Aaron Blackshaw; Andrew Jakymiw
Journal:  Mol Cancer       Date:  2014-08-13       Impact factor: 27.401

5.  Hyaluronan synthase 3 mediated oncogenic action through forming inter-regulation loop with tumor necrosis factor alpha in oral cancer.

Authors:  Yi-Zih Kuo; Wei-Yu Fang; Cheng-Chih Huang; Sen-Tien Tsai; Yi-Ching Wang; Chih-Li Yang; Li-Wha Wu
Journal:  Oncotarget       Date:  2017-02-28

6.  Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma.

Authors:  Jennifer Bryant; Nikolaos Batis; Anna Clara Franke; Gabriella Clancey; Margaret Hartley; Gordon Ryan; Jill Brooks; Andrew D Southam; Nicholas Barnes; Joanna Parish; Sally Roberts; Farhat Khanim; Rachel Spruce; Hisham Mehanna
Journal:  Oncotarget       Date:  2019-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.